Previous 10 | Next 10 |
CINCINNATI, July 13, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today provided preliminary revenue results for its third quarter of fiscal 2021. Preliminary unaudited revenue for the thi...
gguy44/iStock via Getty Images Piper Sandler Technical Market Strategist Craig. W. Johnson issued his July Alpha Alignment Report, which screens 900 stocks for a host of fundamental and technical factors. Along with the headline Alpha Alignment Index, the report also screens for an equal-weig...
A rapid increase in Delta variant spread in the world may be good news for Meridian's testing supply business. Meridian valuations are discounting the end of the U.S. pandemic this summer, which is far from certain going into the autumn. A sizable short interest position has been ...
Meridian Bioscience ([[VIVO]] +0.8%) has re-submitted its application for Emergency Use Authorization ((EUA)) to the U.S. FDA for the company’s SARS-CoV-2 molecular diagnostic test on the Revogene platform.Shares up more than 12% YTD.The company had voluntarily withdrew ...
CINCINNATI, June 28, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has re-submitted its application for Emergency Use Authorization (EUA) to the U.S. Food and Drug Adminis...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IHF. A list of cheap stocks. For further details see: IHF: Healthcare Dashboard For June
CINCINNATI, June 16, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of the Lyo-Ready™ RT-LAMP Mix, specifically designed for accelerating the development of ambie...
Gainers: BriaCell Therapeutics BCTX +151%, Constellation Pharmaceuticals CNST +67%, Soleno Therapeutics SLNO +46%, Stealth BioTherapeutics (MITO) +24%, Aerpio Pharmaceuticals (ARPO) +9%.Losers: iRhythm Technologies IRTC -18%, Progenity (P...
CINCINNATI, May 27, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today participation in two upcoming investor conferences. Jack Kenny, Chief Executive Officer, will participate in a live, virtual fireside chat at the 41 st Annual William Blair Growth Stock...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. A list of cheap stocks. For further details see: IYH: Healthcare Dashboard For May
News, Short Squeeze, Breakout and More Instantly...
Meridian Bioscience Inc. Company Name:
VIVO Stock Symbol:
NASDAQ Market:
Meridian Bioscience Inc. Website:
Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter. Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021. Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year. The Company signed a definitive agreemen...
Toronto, Ontario--(Newsfile Corp. - March 24, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that it has obtained a final court order (the " Final Order ") from the Ontario Superior Court of Justice (Commercial List) approving the previously announced pl...
Toronto, Ontario--(Newsfile Corp. - March 21, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that, at the special meeting of the shareholders of VIVO (the " Shareholders ") held today (the " Meeting "), the Shareholders approved (i) a special resolutio...